Search Results - "DI RAIMONDO, F."

The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries by Hoffmann, V S, Baccarani, M, Hasford, J, Lindoerfer, D, Burgstaller, S, Sertic, D, Costeas, P, Mayer, J, Indrak, K, Everaus, H, Koskenvesa, P, Guilhot, J, Schubert-Fritschle, G, Castagnetti, F, Di Raimondo, F, Lejniece, S, Griskevicius, L, Thielen, N, Sacha, T, Hellmann, A, Turkina, A G, Zaritskey, A, Bogdanovic, A, Sninska, Z, Zupan, I, Steegmann, J-L, Simonsson, B, Clark, R E, Covelli, A, Guidi, G, Hehlmann, R

“…This population-based registry was designed to provide robust and updated information on the characteristics and the epidemiology of chronic myeloid leukemia…”
Get full text

Treatment and outcome of 2904 CML patients from the EUTOS population-based registry by Hoffmann, V S, Baccarani, M, Hasford, J, Castagnetti, F, Di Raimondo, F, Casado, L F, Turkina, A, Zackova, D, Ossenkoppele, G, Zaritskey, A, Höglund, M, Simonsson, B, Indrak, K, Sninska, Z, Sacha, T, Clark, R, Bogdanovic, A, Hellmann, A, Griskevicius, L, Schubert-Fritschle, G, Sertic, D, Guilhot, J, Lejniece, S, Zupan, I, Burgstaller, S, Koskenvesa, P, Everaus, H, Costeas, P, Lindoerfer, D, Rosti, G, Saussele, S, Hochhaus, A, Hehlmann, R

“…The European Treatment and Outcome Study (EUTOS) population-based registry includes data of all adult patients newly diagnosed with Philadelphia…”
Get full text

Treatment of Older Patients with Mantle-Cell Lymphoma by Kluin-Nelemans, H.C, Hoster, E, Hermine, O, Walewski, J, Trneny, M, Geisler, C.H, Stilgenbauer, S, Thieblemont, C, Vehling-Kaiser, U, Doorduijn, J.K, Coiffier, B, Forstpointner, R, Tilly, H, Kanz, L, Feugier, P, Szymczyk, M, Hallek, M, Kremers, S, Lepeu, G, Sanhes, L, Zijlstra, J.M, Bouabdallah, R, Lugtenburg, P.J, Macro, M, Pfreundschuh, M, Procházka, V, Di Raimondo, F, Ribrag, V, Uppenkamp, M, André, M, Klapper, W, Hiddemann, W, Unterhalt, M, Dreyling, M.H

“…This international prospective study showed that maintenance therapy with rituximab was more effective than interferon alfa in prolonging the duration of…”
Get full text

High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling by Romano, A., Parrinello, N. L., Simeon, V., Puglisi, F., La Cava, P., Bellofiore, C., Giallongo, C., Camiolo, G., D’Auria, F., Grieco, V., Larocca, F., Barbato, A., Cambria, D., La Spina, E., Tibullo, D., Palumbo, G. A., Conticello, C., Musto, P., Di Raimondo, F.

“…To understand neutrophil impairment in the progression from MGUS through active MM, we investigated the function of mature, high-density neutrophils (HDNs),…”
Get full text

NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components by Pozzo, F, Bittolo, T, Vendramini, E, Bomben, R, Bulian, P, Rossi, F M, Zucchetto, A, Tissino, E, Degan, M, D’Arena, G, Di Raimondo, F, Zaja, F, Pozzato, G, Rossi, D, Gaidano, G, Del Poeta, G, Gattei, V, Dal Bo, M

“…In chronic lymphocytic leukemia (CLL), the mechanisms controlling cell growth and proliferation in the presence of NOTCH1 mutations remain largely unexplored…”
Get full text

Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma by Cavo, M, Pantani, L, Pezzi, A, Petrucci, M T, Patriarca, F, Di Raimondo, F, Marzocchi, G, Galli, M, Montefusco, V, Zamagni, E, Gamberi, B, Tacchetti, P, Brioli, A, Palumbo, A, Sonneveld, P

Get full text

CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia by Dal Bo, M, Bulian, P, Bomben, R, Zucchetto, A, Rossi, F M, Pozzo, F, Tissino, E, Benedetti, D, Bittolo, T, Nanni, P, Cattarossi, I, Zaina, E, Chivilò, H, Degan, M, Zaja, F, Pozzato, G, Chiarenza, A, Di Raimondo, F, Del Principe, M I, Del Poeta, G, Rossi, D, Gaidano, G, Gattei, V

“…CD49d, the alpha-chain of the integrin heterodimer α4β1, was identified among the strongest predictors of overall survival (OS) in chronic lymphocytic leukemia…”
Get full text

MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes by Giallongo, C., Dulcamare, I., Giallongo, S., Duminuco, A., Pieragostino, D., Cufaro, M. C., Amorini, A. M., Lazzarino, G., Romano, A., Parrinello, N., Di Rosa, M., Broggi, G., Caltabiano, R., Caraglia, M., Scrima, M., Pasquale, L. S., Tathode, M. S., Li Volti, G., Motterlini, R., Di Raimondo, F., Tibullo, D., Palumbo, G. A.

“…Ineffective hematopoiesis is a hallmark of myelodysplastic syndromes (MDS). Hematopoietic alterations in MDS patients strictly correlate with microenvironment…”
Get full text

A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients by Gentile, M, Shanafelt, T D, Cutrona, G, Molica, S, Tripepi, G, Alvarez, I, Mauro, F R, Di Renzo, N, Di Raimondo, F, Vincelli, I, Todoerti, K, Matis, S, Musolino, C, Fabris, S, Vigna, E, Levato, L, Zupo, S, Angrilli, F, Consoli, U, Festini, G, Longo, G, Cortelezzi, A, Arcari, A, Federico, M, Mannina, D, Recchia, A G, Neri, A, Kay, N E, Ferrarini, M, Morabito, F

Get full text

Successful coronary artery bypass graft surgery in severe congenital factor VII deficiency: Perioperative treatment with pd‐factor VII concentrate by Giuffrida, G., Nicolosi, D., Giuffrida, A., Rapisarda, C., Calafiore, V., Giuffrida, A., Di Raimondo, F.

Get full text

Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands? by Benedetti, D, Tissino, E, Caldana, C, Dal Bo, M, Bomben, R, Marconi, D, Ganghammer, S, Zaja, F, Pozzato, G, Di Raimondo, F, Hartmann, T N, Del Poeta, G, VanMeter, A, Zucchetto, A, Espina, V, Liotta, L, Gattei, V

Get full text

Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis by Magni, M, Nicola, M Di, Patti, C, Scimè, R, Mulè, A, Rambaldi, A, Intermesoli, T, Viero, P, Tarella, C, Gueli, A, Bergui, L, Trentin, L, Barzan, A, Benedetti, F, Ambrosetti, A, Di Raimondo, F, Chiarenza, A, Parvis, G, Billio, A, Attolico, I, Olivieri, A, Montanari, M, Carlo-Stella, C, Matteucci, P, Devizzi, L, Guidetti, A, Viviani, S, Valagussa, P, Gianni, A M

“…The importance of early therapy intensification in B-cell CLL (B-CLL) patients remains to be defined. Even though several studies have been published, no…”
Get full text

A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia by Martelli, M P, Manes, N, Liso, A, Pettirossi, V, Verducci Galletti, B, Bigerna, B, Pucciarini, A, De Marco, M F, Pallotta, M T, Bolli, N, Sborgia, M, di Raimondo, F, Fabbiano, F, Meloni, G, Specchia, G, Martelli, M F, Falini, B

Get full text

Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma? by Di Raimondo, F., Caruso, L., Bonanno, G., Naso, P., Chiarenza, A., Fiumara, P., Bari, A., Palumbo, G.A., Russo, A., Giustolisi, R.

“…Background: Endoscopic ultrasound (EUS) is considered the best technique for locoregional staging at diagnosis but its role in the follow-up of patients with…”
Get full text

Acute megakaryoblastic leukemia: experience of GIMEMA trials by PAGANO, L, PULSONI, A, SPECCHIA, G, DI RAIMONDO, F, PACILLI, L, LEONI, P, LADOGANA, S, GALLO, E, VENDITTI, A, AVANZI, G, CAMERA, A, LISO, V, VIGNETTI, M, LEONE, G, MANDELLI, F, MELE, L, FIANCHI, L, PETTI, M. C, MIRTO, S, FALCUCCI, P, FAZI, P, BROCCIA, G

“…The objective of the study was to evaluate the incidence, characteristics, treatment and outcome of acute megakaryoblastic leukemia (AMeL) in patients enrolled…”
Get full text

Management and long-term follow-up of early stage H. pylori -associated gastric MALT-lymphoma in clinical practice: An Italian, multicentre study by Andriani, A, Miedico, A, Tedeschi, L, Patti, C, Di Raimondo, F, Leone, M, Schinocca, L, Romanelli, A, Bonanno, G, Linea, C, Giustini, M, Hassan, C, Cottone, M, Zullo, A

“…Abstract Background/Aim Data on management and long-term follow-up of Helicobacter pylori -associated MALT-lymphoma in clinical practice are scanty. We…”
Get full text

Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study by Hochhaus, Andreas, Gambacorti-Passerini, Carlo, Abboud, Camille, Gjertsen, Bjørn Tore, Brümmendorf, Tim H., Smith, B. Douglas, Ernst, Thomas, Giraldo-Castellano, Pilar, Olsson-Strömberg, Ulla, Saussele, Susanne, Bardy-Bouxin, Nathalie, Viqueira, Andrea, Leip, Eric, Russell-Smith, T. Alexander, Leone, Jocelyn, Rosti, Gianantonio, Watts, Justin, Giles, Francis J.

“…Bosutinib is approved for newly diagnosed Philadelphia chromosome-positive (Ph+) chronic phase (CP) chronic myeloid leukemia (CML) and for Ph+ CP, accelerated…”
Get full text

The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi by Luminari, S., Biasoli, I., Arcaini, L., Versari, A., Rusconi, C., Merli, F., Spina, M., Ferreri, A.J.M., Zinzani, P.L., Gallamini, A., Mastronardi, S., Boccomini, C., Gaidano, G., D'Arco, A.M., Di Raimondo, F., Carella, A.M., Santoro, A., Musto, P., Federico, M.

“…The role of [18F] fluorodeoxyglucose (FDG)-positron emission tomography (PET) in follicular lymphoma (FL) staging is not yet determined. The aim of the present…”
Get full text

Abnormal F-18 Fluorodeoxyglucose Uptake of the Lung in Immunocompromised Lymphoma Patients in Complete Remission: Report of Two Cases and Revision of Literature by Conticello, C., Vetro, C., Romano, A., Amato, G., Schinocca, L., Cosentino, S., Ippolito, M., Giustolisi, R., Di Raimondo, F.

“…Limited data suggest that F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) may have a role in diagnosing infection. Here we present two cases…”
Get full text

Impact of complete response on progression-free survival and overall survival in newly diagnosed myeloma patients treated with autologous stem cell transplantation or conventional chemotherapy: results of a pooled analysis of 5 phase III trials by Mina, R, Larocca, A, Offidani, M, Magarotto, V, Caravita, T, van der Holt, R, Di Raimondo, F, Bosi, A, Vincelli, I.D, Croockewit, S, Gaidano, G, Grandi, S, Musolino, C, Cerrato, C, Lud k, P, Ruggeri, M, Rossi, G, Rossini, F, Petrucci, M.T, Ria, R, Zweegman, S, Hajek, R, Spencer, A, Boccadoro, M, Sonneveld, P, Palumbo, A

Get full text